{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:34:44Z","timestamp":1787495684582,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671915"],"award-info":[{"award-number":["81671915"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13046-019-1138-7","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T03:02:56Z","timestamp":1553742176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["TRIM44 activates the AKT\/mTOR signal pathway to induce melanoma progression by stabilizing TLR4"],"prefix":"10.1186","volume":"38","author":[{"given":"Chuan-Yuan","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Xuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Hui","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Fan","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Qi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-Zhi","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,28]]},"reference":[{"key":"1138_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"Schadendorf D, van Akkooi A, Berking C, Griewank KG, Gutzmer R, Hauschild A, et al. Melanoma. Lancet. 2018;392:971\u201384.","journal-title":"Lancet"},{"key":"1138_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"1138_CR3","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/nrc3139","volume":"11","author":"S Hatakeyama","year":"2011","unstructured":"Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer. 2011;11:792\u2013804.","journal-title":"Nat Rev Cancer"},{"key":"1138_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrm1124","volume":"4","author":"PP Fiore Di","year":"2003","unstructured":"Di Fiore PP, Polo S, Hofmann K. When ubiquitin meets ubiquitin receptors: a signalling connection. Nat Rev Mol Cell Biol. 2003;4:491\u20137.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1138_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425\u201379.","journal-title":"Annu Rev Biochem"},{"key":"1138_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.tibs.2017.01.002","volume":"42","author":"S Hatakeyama","year":"2017","unstructured":"Hatakeyama S. TRIM family proteins: roles in autophagy, immunity, and carcinogenesis. Trends Biochem Sci. 2017;42:297\u2013311.","journal-title":"Trends Biochem Sci"},{"key":"1138_CR7","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/s41467-017-01731-w","volume":"8","author":"D Lv","year":"2017","unstructured":"Lv D, Li Y, Zhang W, Alvarez AA, Song L, Tang J, et al. TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma. Nat Commun. 2017;8:1454.","journal-title":"Nat Commun"},{"key":"1138_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbrc.2009.04.010","volume":"383","author":"T Urano","year":"2009","unstructured":"Urano T, Usui T, Takeda S, Ikeda K, Okada A, Ishida Y, et al. TRIM44 interacts with and stabilizes terf, a TRIM ubiquitin E3 ligase. Biochem Biophys Res Commun. 2009;383:263\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"1138_CR9","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.4049\/jimmunol.1202507","volume":"190","author":"B Yang","year":"2013","unstructured":"Yang B, Wang J, Wang Y, Zhou H, Wu X, Tian Z, et al. Novel function of Trim44 promotes an antiviral response by stabilizing VISA. J Immunol. 2013;190:3613\u20139.","journal-title":"J Immunol"},{"key":"1138_CR10","doi-asserted-by":"crossref","unstructured":"Chen Z, Lin TC, Bi X, Lu G, Dawson BC, Miranda R, et al. TRIM44 promotes quiescent multiple myeloma cell occupancy and survival in the osteoblastic niche via HIF-1alpha stabilization. Leukemia. 2018;33:469\u201386.","DOI":"10.1038\/s41375-018-0222-x"},{"key":"1138_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrgastro.2012.210","volume":"10","author":"S Song","year":"2013","unstructured":"Song S, Ajani JA. The role of microRNAs in cancers of the upper gastrointestinal tract. Nat Rev Gastroenterol Hepatol. 2013;10:109\u201318.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1138_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"1138_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg2843","volume":"11","author":"J Krol","year":"2010","unstructured":"Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11:597\u2013610.","journal-title":"Nat Rev Genet"},{"key":"1138_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"Hayes J, Peruzzi PP, Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014;20:460\u20139.","journal-title":"Trends Mol Med"},{"key":"1138_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203\u201322.","journal-title":"Nat Rev Drug Discov"},{"key":"1138_CR16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1101\/gad.233585.113","volume":"28","author":"N Okada","year":"2014","unstructured":"Okada N, Lin CP, Ribeiro MC, Biton A, Lai G, He X, et al. A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev. 2014;28:438\u201350.","journal-title":"Genes Dev"},{"key":"1138_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nm.2284","volume":"17","author":"C Liu","year":"2011","unstructured":"Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011;17:211\u20135.","journal-title":"Nat Med"},{"key":"1138_CR18","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.2147\/OTT.S163163","volume":"11","author":"H Wang","year":"2018","unstructured":"Wang H, Fang ZL, Zhang GH, Ma X. TRIM44, a crucial target of miR-410, functions as a potential oncogene in osteosarcoma. Onco Targets Ther. 2018;11:3637\u201347.","journal-title":"Onco Targets Ther"},{"key":"1138_CR19","doi-asserted-by":"crossref","unstructured":"Wei CY, Zhu MX, Lu NH, Peng R, Yang X, Zhang PF, et al. Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma. Oncogene. 2018;38:1876\u201391.","DOI":"10.1038\/s41388-018-0531-6"},{"key":"1138_CR20","first-page":"2553","volume":"39","author":"C Wei","year":"2018","unstructured":"Wei C, Lu N, Wang L, Zhang Y, Feng Z, Yang Y, et al. Upregulation of UHRF1 promotes the progression of melanoma by inducing cell proliferation. Oncol Rep. 2018;39:2553\u201362.","journal-title":"Oncol Rep"},{"key":"1138_CR21","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/hep.27682","volume":"61","author":"JB Cai","year":"2015","unstructured":"Cai JB, Shi GM, Dong ZR, Ke AW, Ma HH, Gao Q, et al. Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression. Hepatology. 2015;61:1603\u201314.","journal-title":"Hepatology"},{"key":"1138_CR22","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1053\/j.gastro.2011.02.008","volume":"140","author":"AW Ke","year":"2011","unstructured":"Ke AW, Shi GM, Zhou J, Huang XY, Shi YH, Ding ZB, et al. CD151 amplifies signaling by integrin alpha6beta1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells. Gastroenterology. 2011;140:1629\u201341.e15.","journal-title":"Gastroenterology"},{"key":"1138_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41419-018-0577-y","volume":"9","author":"C Luo","year":"2018","unstructured":"Luo C, Yin D, Zhan H, Borjigin U, Li C, Zhou Z, et al. microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A. Cell Death Dis. 2018;9:535.","journal-title":"Cell Death Dis"},{"key":"1138_CR24","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/cam4.1313","volume":"7","author":"R Peng","year":"2018","unstructured":"Peng R, Zhang PF, Zhang C, Huang XY, Ding YB, Deng B, et al. Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling. Cancer Med. 2018;7:796\u2013808.","journal-title":"Cancer Med"},{"key":"1138_CR25","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1111\/cas.13762","volume":"109","author":"D Xiong","year":"2018","unstructured":"Xiong D, Jin C, Ye X, Qiu B, Jianjun X, Zhu S, et al. TRIM44 promotes human esophageal cancer progression via the AKT\/mTOR pathway. Cancer Sci. 2018;109:3080\u201392.","journal-title":"Cancer Sci"},{"key":"1138_CR26","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3390\/ijms18091931","volume":"18","author":"H Kawabata","year":"2017","unstructured":"Kawabata H, Azuma K, Ikeda K, Sugitani I, Kinowaki K, Fujii T, et al. TRIM44 is a poor prognostic factor for breast Cancer patients as a modulator of NF-kappaB signaling. Int J Mol Sci. 2017;18:1931.","journal-title":"Int J Mol Sci"},{"key":"1138_CR27","doi-asserted-by":"crossref","first-page":"30479","DOI":"10.18632\/oncotarget.8586","volume":"7","author":"Y Xing","year":"2016","unstructured":"Xing Y, Meng Q, Chen X, Zhao Y, Liu W, Hu J, et al. TRIM44 promotes proliferation and metastasis in nonsmall cell lung cancer via mTOR signaling pathway. Oncotarget. 2016;7:30479\u201391.","journal-title":"Oncotarget"},{"key":"1138_CR28","doi-asserted-by":"publisher","first-page":"e72699","DOI":"10.1371\/journal.pone.0072699","volume":"8","author":"J Kozubek","year":"2013","unstructured":"Kozubek J, Ma Z, Fleming E, Duggan T, Wu R, Shin DG, et al. In-depth characterization of microRNA transcriptome in melanoma. PLoS One. 2013;8:e72699.","journal-title":"PLoS One"},{"key":"1138_CR29","doi-asserted-by":"crossref","first-page":"24383","DOI":"10.18632\/oncotarget.8328","volume":"7","author":"Y Wang","year":"2016","unstructured":"Wang Y, Sun B, Zhao X, Zhao N, Sun R, Zhu D, et al. Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma. Oncotarget. 2016;7:24383\u2013401.","journal-title":"Oncotarget"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1138-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-019-1138-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1138-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T23:31:18Z","timestamp":1607038278000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-019-1138-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1138"],"URL":"https:\/\/doi.org\/10.1186\/s13046-019-1138-7","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,28]]},"assertion":[{"value":"21 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Zhongshan Hospital Biomedical Research Department and written consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"137"}}